Search
for
Sort by
Research 631–660 of 1000+
- Phytochemicals in the Management of Polycystic Ovary Syndrome, Endometriosis, and Menstrual Irregularities
- A cross-specialty expert opinion on the management of hair loss in gynaecological and endocrinological disorders in Indian patients
- Multidimensional assessment of adverse events of finasteride：a real-world pharmacovigilance analysis based on FDA Adverse Event Reporting System (FAERS) from 2004 to April 2024
- Polycystic Ovary Syndrome: A Comprehensive Review of Its Clinical Presentation, Comorbidities, Long-Term Complications and Management
- Exploring Herbal Alternatives to Pharmaceutical Treatments for Polycystic Ovary Syndrome
- A Single Blind Randomized Control Study to Endeavor the Effect of Wiesbaden Dilution 30C in the Treatment of Telogen Effluvium
- Studying the relationship betweenSerum Copper levels and Vitamin D in Alopecia Areata patients with Controls in India
- EFFECTS OF HORMONAL THERAPY IN TRANSGENDERS
- Ageratum Conyzoides L. Extract Inhibits 5α-Reductase Gene Expression and Prostaglandin D2 Release in Human Hair Dermal Papilla Cells and Improves Symptoms of Hair Loss in Otherwise Healthy Males and Females in an Open Label Pilot Study
- Recommendations on trichological treatments during COVID-19 pandemic
- A Review on Nanoparticle Based Herbal Remedies for the Management of Alopecia
- Telogen Effluvium
- General Dermatology
- Il trattamento con metformina e clomifene citrato nelle donne con sindrome dell’ovaio policistico e infertilità
- SUMMARIES OF PAPERS
- The childbearing years: hair diseases
- A comparison of cabergoline and bromocriptine in the treatment of hyperprolactinemic amenorrhea
- Evaluation of serum G protein-coupled estrogen receptor 1 (GPER-1) levels in patients with androgenetic alopecia
- Adverse health effects of androgen use
- Potential Medical Uses of Cannabigerol: A Brief Overview
- Hyperadrenocorticism in Ferrets
- Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome
- Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)
- Standards of Care for the Health of Transsexual, Transgender, and Gender-Nonconforming People, Version 7
- The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report
- Polycystic ovary syndrome: etiology, pathogenesis and diagnosis
- Assessment of Cardiovascular Risk and Prevention of Cardiovascular Disease in Women with the Polycystic Ovary Syndrome: A Consensus Statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society
- Androgen Therapy in Women: An Endocrine Society Clinical Practice Guideline
- Prevalence of polycystic ovary syndrome in women in China: a large community-based study
- Bioavailability of Albumin-Bound Testosterone†